Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Abeona Therapeutics Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 100 | 104 | +4 |
| Shares | 35.6M | 38.9M | +3.35M (+9.4%) |
| Value | $187.9M | $205.2M | +$17.3M (+9.2%) |
New holders (22)
Institutions that held Abeona Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (18)
Institutions that held Abeona Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 3,047,985 | $16.1M |
| Western Standard LLC | 1,249,957 | $6.60M |
| Boone Capital Management LLC | 502,854 | $2.66M |
| Newtyn Management, LLC | 248,656 | $1.31M |
| Qube Research & Technologies Ltd | 225,868 | $1.19M |
| Trexquant Investment LP | 177,754 | $938.5K |
| Wellington Management Group LLP | 150,929 | $796.9K |
| Prudential Financial Inc | 37,311 | $197.0K |
| Squarepoint Ops LLC | 21,316 | $112.5K |
| Boothbay Fund Management, LLC | 17,816 | $94.1K |
| Creative Planning | 17,762 | $93.8K |
| Omers Administration Corp | 13,400 | $70.8K |
| Marshall Wace, LLP | 11,800 | $62.3K |
| Sunbelt Securities, Inc. | 1,500 | $7.92K |
| Signaturefd, LLC | 687 | $3.63K |
| Quadrant Capital Group LLC | 667 | $3.52K |
| SRS Capital Advisors, Inc. | 279 | $1.47K |
| Massmutual Trust Co FSB | 126 | $665 |